| Year |
Citation |
Score |
| 2018 |
Alapafuja SO, Malamas MS, Shukla V, Zvonok A, Miller S, Daily L, Rajarshi G, Miyabe CY, Chandrashekhar H, Wood J, Tyukhtenko S, Straiker A, Makriyannis A. Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment. Bioorganic & Medicinal Chemistry. PMID 30446439 DOI: 10.1016/j.bmc.2018.11.003 |
0.32 |
|
| 2017 |
Leonard MZ, Alapafuja SO, Ji L, Shukla VG, Liu Y, Nikas SP, Makriyannis A, Bergman J, Kangas BD. Cannabinoid CB1 Discrimination: Effects of Endocannabinoids and Catabolic Enzyme Inhibitors. The Journal of Pharmacology and Experimental Therapeutics. PMID 28947487 DOI: 10.1124/jpet.117.244392 |
0.32 |
|
| 2017 |
Farizatto KLG, McEwan SA, Naidoo V, Nikas SP, Shukla VG, Almeida MF, Byrd A, Romine H, Karanian DA, Makriyannis A, Bahr BA. Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo Neurotoxic Effects of Paraoxon. Journal of Molecular Neuroscience : Mn. PMID 28803438 DOI: 10.1007/s12031-017-0963-4 |
0.32 |
|
| 2016 |
Kangas BD, Leonard MZ, Shukla VG, Alapafuja SO, Nikas SP, Makriyannis A, Bergman J. Comparisons of Δ9-tetrahydrocannabinol and Anandamide on a Battery of Cognition-related Behavior in Nonhuman Primates. The Journal of Pharmacology and Experimental Therapeutics. PMID 26826191 DOI: 10.1124/jpet.115.228189 |
0.32 |
|
| 2015 |
Janero DR, Yaddanapudi S, Zvonok N, Subramanian KV, Shukla VG, Stahl E, Zhou L, Hurst D, Wager-Miller J, Bohn LM, Reggio PH, Mackie K, Makriyannis A. Molecular-Interaction and Signaling Profiles of AM3677, a Novel Covalent Agonist Selective for the Cannabinoid 1 Receptor. Acs Chemical Neuroscience. PMID 25978068 DOI: 10.1021/acschemneuro.5b00090 |
0.32 |
|
| 2015 |
Tai S, Nikas SP, Shukla VG, Vemuri K, Makriyannis A, Järbe TU. Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist. Psychopharmacology. 232: 2751-61. PMID 25772338 DOI: 10.1007/s00213-015-3907-0 |
0.32 |
|
| 2013 |
Kangas BD, Delatte MS, Vemuri VK, Thakur GA, Nikas SP, Subramanian KV, Shukla VG, Makriyannis A, Bergman J. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists. The Journal of Pharmacology and Experimental Therapeutics. 344: 561-7. PMID 23287700 DOI: 10.1124/jpet.112.201962 |
0.32 |
|
| 2012 |
Alapafuja SO, Nikas SP, Bharathan IT, Shukla VG, Nasr ML, Bowman AL, Zvonok N, Li J, Shi X, Engen JR, Makriyannis A. Sulfonyl fluoride inhibitors of fatty acid amide hydrolase. Journal of Medicinal Chemistry. 55: 10074-89. PMID 23083016 DOI: 10.1021/jm301205j |
0.32 |
|
| 2012 |
Paronis CA, Nikas SP, Shukla VG, Makriyannis A. Δ(9)-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice. Behavioural Pharmacology. 23: 802-5. PMID 23075707 DOI: 10.1097/FBP.0b013e32835a7c4d |
0.32 |
|
| 2012 |
Karageorgos I, Zvonok N, Janero DR, Vemuri VK, Shukla V, Wales TE, Engen JR, Makriyannis A. Endocannabinoid enzyme engineering: soluble human thio-monoacylglycerol lipase (sol-S-hMGL). Acs Chemical Neuroscience. 3: 393-9. PMID 22860208 DOI: 10.1021/cn3000263 |
0.32 |
|
| 2012 |
Dixon DD, Tius MA, Thakur GA, Zhou H, Bowman AL, Shukla VG, Peng Y, Makriyannis A. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor. Bioorganic & Medicinal Chemistry Letters. 22: 5322-5. PMID 22796181 DOI: 10.1016/j.bmcl.2012.06.013 |
0.32 |
|
| 2012 |
Naidoo V, Karanian DA, Vadivel SK, Locklear JR, Wood JT, Nasr M, Quizon PM, Graves EE, Shukla V, Makriyannis A, Bahr BA. Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase - dual targets of the endocannabinoid system to protect against seizure pathology. Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 9: 801-13. PMID 22270809 DOI: 10.1007/s13311-011-0100-y |
0.32 |
|
| 2012 |
Järbe TU, Tai S, LeMay BJ, Nikas SP, Shukla VG, Zvonok A, Makriyannis A. AM2389, a high-affinity, in vivo potent CB1-receptor-selective cannabinergic ligand as evidenced by drug discrimination in rats and hypothermia testing in mice. Psychopharmacology. 220: 417-26. PMID 21989802 DOI: 10.1007/s00213-011-2491-1 |
0.32 |
|
| 2010 |
Nikas SP, Alapafuja SO, Papanastasiou I, Paronis CA, Shukla VG, Papahatjis DP, Bowman AL, Halikhedkar A, Han X, Makriyannis A. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist. Journal of Medicinal Chemistry. 53: 6996-7010. PMID 20925434 DOI: 10.1021/jm100641g |
0.32 |
|
| 2009 |
Alapafuja SO, Nikas SP, Shukla VG, Papanastasiou I, Makriyannis A. Microwave Assisted Synthesis of Sodium Sulfonates Precursors of Sulfonyl Chlorides and Fluorides. Tetrahedron Letters. 50: 7028-7031. PMID 21132105 DOI: 10.1016/j.tetlet.2009.09.167 |
0.32 |
|
| 2007 |
Salgaonkar PD, Shukla VG, Akamanchi KG. α-bromination of 1,3-dicarbonyl compounds using Dess-Martin periodinane (DMP) and tetraethylammonium bromide (TEAB) Synthetic Communications. 37: 275-280. DOI: 10.1080/00397910601033641 |
0.32 |
|
| 2005 |
Salgaonkar PD, Shukla VG, Akamanchi KG. Iodic acid (HIO3) in combination with tetraethylammonium bromide as a catalyst for selective and accelerated sulfoxidation Synthetic Communications. 35: 2805-2810. DOI: 10.1080/00397910500290540 |
0.32 |
|
| 2005 |
Shukla VG, Salgaonkar PD, Akamanchi KG. A first example using o-iodoxybenzoic acid (IBX) in combination with tetraethylammonium bromide (TEAB) for ring expansion of 1,3-dithiolanes and 1,3-dithianes Synlett. 1483-1485. DOI: 10.1055/s-2005-868496 |
0.32 |
|
| 2003 |
Shukla VG, Salgaonkar PD, Akamanchi KG. A mild, chemoselective oxidation of sulfides to sulfoxides using o-iodoxybenzoic acid and tetraethylammonium bromide as catalyst. The Journal of Organic Chemistry. 68: 5422-5. PMID 12816514 DOI: 10.1021/jo034483b |
0.32 |
|
| 2002 |
Ramanarayanan GV, Shukla VG, Akamanchi KG. A novel and one step procedure for preparation of α-bromo-α,β-unsaturated carbonyl compounds Synlett. 2059-2061. DOI: 10.1002/chin.200310051 |
0.32 |
|
| Show low-probability matches. |